Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143810 |
| CAS No | NA |
| Mol.F. | C17H14D3F3N2O2 |
| Mol.Wt. | 341.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143811 |
| CAS No | NA |
| Mol.F. | C17H12D5F3N2O2 |
| Mol.Wt. | 343.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143812 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143813 |
| CAS No | NA |
| Mol.F. | C14H13D3N4O2 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143814 |
| CAS No | NA |
| Mol.F. | C11H18N2O3 |
| Mol.Wt. | 226.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143815 |
| CAS No | NA |
| Mol.F. | C18H21F6N3O4 |
| Mol.Wt. | 457.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143816 |
| CAS No | NA |
| Mol.F. | C19H21FN4O5 |
| Mol.Wt. | 404.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143817 |
| CAS No | NA |
| Mol.F. | C11H6F2N2O5 |
| Mol.Wt. | 284.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143818 |
| CAS No | NA |
| Mol.F. | C10H4F2N2O5 |
| Mol.Wt. | 270.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143819 |
| CAS No | NA |
| Mol.F. | C13H10F2N2O5 |
| Mol.Wt. | 312.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143820 |
| CAS No | NA |
| Mol.F. | C19H38N6O8 |
| Mol.Wt. | 478.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143821 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143822 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143823 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143824 |
| CAS No | NA |
| Mol.F. | C20H40N6O8 |
| Mol.Wt. | 492.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |